Letermovir
APICAS: 917389-32-3
Sample Stock:
Letermovir is a first-in-class antiviral medication designed to prevent cytomegalovirus (CMV) infection in adults who have received an allogeneic hematopoietic stem cell transplant (HSCT).
Related Information
Purity:98%+
Registration:GMP/DMF
Key Intermediates
2 Items| Structure | Name | CAS No. | Sample Stock | MDL No. | Details |
|---|---|---|---|---|---|
![4-QuinazolineAcetic Acid 8-Fluoro-1,2,3,4-Tetrahydro-3-[2-Methoxy-5-(TrifluoroMethyl)Phenyl]-2-Oxo-Methyl ester structure](https://static.dempochem.com/structures-bw/693689683c39713e13a15cc3.svg) | 4-QuinazolineAcetic Acid 8-Fluoro-1,2,3,4-Tetrahydro-3-[2-Methoxy-5-(TrifluoroMethyl)Phenyl]-2-Oxo-Methyl ester | 917389-21-0 | MFCD28144588 | ||
 | N-(3-Methoxyphenyl)piperazine hydrochloride | 16015-70-6 | MFCD08448702 |